Why Is MS a More Frequent Complication of EBV Infection in Females?
Immunological Reviews · 2026-05 · 339 (1)
DOI: 10.1111/imr.70115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 01.04.2026. Verfasst von Shannon E Dunn und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sunnybrook Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Multiple Sclerosis, Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Multiple sclerosis (MS) is a T helper (Th) cell‐mediated disease that targets central nervous system (CNS) white matter. This disease affects three times more females than males. For many years, the etiology of MS was not well understood and the exact nature of the autoimmune reaction was speculative. It has now become clear that MS is a rare complication of Epstein–Barr Virus (EBV) infection and that the virus induces an EBV nuclear antigen (EBNA‐1)‐specific T and B cell response that is cross‐reactive against a number of CNS antigens including Glial cell‐associated membrane protein (GlialCAM), Anoctamin‐2 (Ano‐2), myelin basic protein (MBP), and alpha‐B‐crystallin (CRYAB). Recent studies have clarified the involvement of the major human leukocyte antigen (HLA) MS risk haplotype, HLA‐DR15, in sustaining autoreactive T cell responses and its interaction with EBV. Here, we overview this literature through the lens that MS is a disease that affects females more than males. We describe how EBV seroprevalence and the incidence of infectious mononucleosis are greater in females during the early teen years, a period of increased MS susceptibility. We overview how females with MS develop greater levels of EBNA‐1‐cross‐reactive autoantibodies and show greater myelin‐specific T helper 1 (Th1) cells in peripheral blood. Finally, we provide evidence that EBV‐infected B cells may achieve a greater state of latency in females and discuss how this may perpetuate CNS autoimmunity. At the same time, our literature search identified many missed opportunities to learn about sex differences in MS. Our hope is that this review will motivate researchers in the future to disaggregate data by sex to accelerate discoveries in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sunnybrook Research Institute, Toronto, Ontario, Canada.
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
- Women's College Research Institute, Toronto, Ontario, Canada.
- Cell and Systems Biology, The Hospital for Sick Children (SickKids) Research Institute, Toronto, Ontario, Canada.
- Neurology and Neurological Sciences, Stanford University, Stanford, California, USA.
ORCID-Profile: Shannon E Dunn
Zitieren
APA
Dunn, S. E., Alvarez-Sanchez, N., & Steinman, L. (2026). Why Is MS a More Frequent Complication of EBV Infection in Females?. Immunological Reviews, 339(1). https://doi.org/10.1111/imr.70115
Vancouver
Dunn SE, Alvarez-Sanchez N, Steinman L. Why Is MS a More Frequent Complication of EBV Infection in Females?. Immunological Reviews. 2026;339(1). doi:10.1111/imr.70115
BibTeX
@article{Dunn2026,
author = {Dunn, Shannon E and Alvarez-Sanchez, Nuria and Steinman, Lawrence},
title = {Why Is MS a More Frequent Complication of EBV Infection in Females?},
journal = {Immunological Reviews},
year = {2026},
volume = {339},
number = {1},
doi = {10.1111/imr.70115}
}
EUVIMED